Baxter Home
Conditions Therapies Products Services About Baxter
Training and Education Sustainability Contact Us
 

Susan R. Lichtenstein

Corporate Vice President and General Counsel

Susan R. Lichtenstein is corporate vice president and general counsel. In this role, she serves as the chief legal officer and is responsible for global communications, government affairs and public policy.

 

Lichtenstein's career has spanned corporate, government, and private law practice. Prior to joining Baxter in March 2005, Lichtenstein served as general counsel to the governor of Illinois. Previously, Lichtenstein worked in the telecommunications industry where she served as general counsel and corporate secretary for both Ameritech Corporation and Tellabs, Inc. She also served as deputy corporation counsel for the City of Chicago after spending a decade with Schiff Hardin & Waite, where she was a partner working on complex litigation, corporate counseling and internal investigations, with particular emphasis on regulated industries.

 

Lichtenstein serves on the boards of numerous civic and philanthropic organizations, including the Lyric Opera of Chicago, the Ravinia Festival, and Olin-Sang-Ruby Union Institute. She is a member of The Economic Club of Chicago, The Executives' Club of Chicago, The Chicago Network and is a steering committee member of the Senior Businesswomen's Forum. Additionally, Lichtenstein was co-founder and co-chair of the Women in Business, Politics and Powers symposium series.

 

Lichtenstein received a Bachelor of Arts from the University of Minnesota and a law degree from Northwestern University Law School.

 

Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.

 
Copyright & Legal Disclaimer  |  Privacy  |   Print this page